API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.ema.europa.eu/en/documents/overview/tenkasi-previously-orbactiv-epar-medicine-overview_en.pdf
https://www.fiercepharma.com/pharma/melinta-bouncing-back-from-bankruptcy-lands-fda-approval-for-speedy-bacterial-skin-infection
https://www.prnewswire.com/news-releases/menarini-group-anuncia-un-acuerdo-comercial-para-vabomere-orbactiv-y-minocin-en-68-pa%C3%ADses-861609999.html
https://www.prnewswire.com/news-releases/menarini-group-anuncia-un-acuerdo-comercial-para-vabomere-orbactiv-y-minocin-en-68-pa%C3%ADses-861609999.html
http://ir.melinta.com/news-releases/news-release-details/melinta-therapeutics-announces-closing-underwritten-public
http://ir.melinta.com/news-releases/news-release-details/melinta-therapeutics-highlight-commitment-antibiotics-and
http://ir.melinta.com/news-releases/news-release-details/melinta-therapeutics-completes-acquisition-medicines-companys